Synopsis of recent research by authors named "Ming-li Sun"
- Ming-Li Sun's recent research predominantly focuses on the protective effects of metformin against doxorubicin-induced cardiotoxicity, including meta-analyses and clinical trials that seek to understand its mechanisms and reliability in animal studies.
- Additionally, Sun is involved in exploring health outcomes linked to intermittent fasting, as shown in a comprehensive umbrella review analyzing systematic reviews and randomized controlled trials.
- His work also encompasses the development of risk assessment models for venous thromboembolism in cancer patients and a systematic review of congenital thrombophilia in East-Asian populations, emphasizing the epidemiology and treatment challenges in these areas.